SCHEMBL3259876

SCHEMBL3259876

CC(=O)C=COC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3259874 1.00
SCHEMBL6059983 0.79
SCHEMBL6059987 0.79
SCHEMBL1883837 0.75 HCAR2 (0.58)
SCHEMBL1878654 0.75 NFE2L2 (0.55)
SCHEMBL1883838 0.75 HCAR2 (0.58)
SCHEMBL1878653 0.75 NFE2L2 (0.55)
SCHEMBL11736176 0.73 TSHR (0.34)
SCHEMBL11736184 0.73 TSHR (0.34)
SCHEMBL17503309 0.73 ALDH1A1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020025499-A1 NEW COMPONENTS FOR ELECTROLYTE COMPOSITIONS SOLVAY SA (BE) 2020-02-06 WO disclosed
EP-2158205-B1 3,3-SPIROINDOLINONE DERIVATIVES AS ANTICANCER AGENTS HOFFMANN LA ROCHE (CH) 2011-12-07 EP disclosed
EP-2158205-A1 3,3-SPIROINDOLINONE DERIVATIVES F. Hoffmann-Roche AG (CH) 2010-03-03 EP disclosed
US-7553833-B2 Rac-(3S,4R,5S)-6'-chloro-3-(3-chlorophenyl)-1,1',2,2',3,5,6,7-octahydro-5-methoxy-spiro[4H-azepine-4,3'-[3H]-indole]-2',7-dione; anticarcinogenic, -tumor, -proliferative agents; ; murine double minute2 (mdm2) antagonists allows accumulation of p53, cell cycle arrest and/or apoptosis HOFFMANN-LA ROCHE INC. (US) 2009-06-30 US disclosed
WO-2008141917-A1 3,3-SPIROINDOLINONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-11-27 WO disclosed
US-20080287421-A1 3,3-SPIROINDOLINONE DERIVATIVES LIU JIN-JUN 2008-11-20 US disclosed